StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Price Performance
Shares of NASDAQ AEZS opened at $1.98 on Friday. The company has a market cap of $9.62 million, a price-to-earnings ratio of -0.58 and a beta of 1.57. The stock’s 50-day moving average is $1.95 and its two-hundred day moving average is $1.90. Aeterna Zentaris has a 1-year low of $1.36 and a 1-year high of $3.38.
Aeterna Zentaris Company Profile
See Also
- Five stocks we like better than Aeterna Zentaris
- What is the Nikkei 225 index?
- United Airlines Soars on Earnings Beat
- What is the Euro STOXX 50 Index?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Investing in Travel Stocks Benefits
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.